Evidence map›Paper›PMID 28849026›Full record

ArticleMolecular medicine reports2017

The effect of Bu Zhong Yi Qi decoction on simulated weightlessness‑induced muscle atrophy and its mechanisms.

Mu Zhu, Zhongyang Liu, Mingze Gao, Yan Zhang, Yuheng Li, Shukuan Ling, Pengfei Zhang, Chenyang Zhao, Lijun Jiang, Yu Liu and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Mu ZhuDepartment of Chinese Materia Medica, School of Preclinical Medicine, Beijing University of Chinese Medicine, Beijing 100019, P.R. China.
Zhongyang LiuState Key Laboratory of Proteomics, Beijing Proteome Research Center, Institute of Radiation Medicine, Beijing 102206, P.R. China.
Mingze GaoDepartment of Chinese Materia Medica, School of Preclinical Medicine, Beijing University of Chinese Medicine, Beijing 100019, P.R. China.
Yan ZhangDepartment of Chinese Materia Medica, School of Preclinical Medicine, Beijing University of Chinese Medicine, Beijing 100019, P.R. China.
Yuheng LiState Key Laboratory of Space Medicine Fundamentals and Applications, China Astronaut Research and Training Center, Beijing 100094, P.R. China.
Shukuan LingState Key Laboratory of Space Medicine Fundamentals and Applications, China Astronaut Research and Training Center, Beijing 100094, P.R. China.
Pengfei ZhangState Key Laboratory of Space Medicine Fundamentals and Applications, China Astronaut Research and Training Center, Beijing 100094, P.R. China.
Chenyang ZhaoState Key Laboratory of Space Medicine Fundamentals and Applications, China Astronaut Research and Training Center, Beijing 100094, P.R. China.
Lijun JiangState Key Laboratory of Space Medicine Fundamentals and Applications, China Astronaut Research and Training Center, Beijing 100094, P.R. China.
Yu LiuState Key Laboratory of Space Medicine Fundamentals and Applications, China Astronaut Research and Training Center, Beijing 100094, P.R. China.
Qi LiState Key Laboratory of Space Medicine Fundamentals and Applications, China Astronaut Research and Training Center, Beijing 100094, P.R. China.
Dong LiState Key Laboratory of Proteomics, Beijing Proteome Research Center, Institute of Radiation Medicine, Beijing 102206, P.R. China.
Sumin HuDepartment of Chinese Materia Medica, School of Preclinical Medicine, Beijing University of Chinese Medicine, Beijing 100019, P.R. China.
Yingxian LiState Key Laboratory of Space Medicine Fundamentals and Applications, China Astronaut Research and Training Center, Beijing 100094, P.R. China.
State Key Laboratory of Space Medicine Fundamentals and ApplicationBeijing University of Chinese Medicine · CNBeijing Proteome Research Center · CNChina Astronaut Research and Training Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microgravity has been previously demonstrated to induce skeletal muscle atrophy, loss of muscle force and disorders in myogenesis and metabolism. Current pharmacological strategies exhibit poor efficacy. Bu Zhong Yi Qi decoction (BZ) is a well‑known traditional Chinese medicine decoction used for myasthenia gravis. In the present study, its effect on unloading induced muscle atrophy was investigated. The mousetail suspension model was used to simulate weightlessness induced muscle atrophy. The results indicated that BZ could significantly protect muscles from simulated weightlessness‑induced atrophy. To elucidate the underlying mechanisms, drugCIPHER‑CS methods were introduced to predict its potential targets, significantly enriched pathways and biological processes. The results demonstrated that the calcium signaling pathway, citrate cycle, biosynthetic and lipid metabolic process are affected by BZ. Among the targets, nuclear receptor corepressor 1 (NCoR1) is one of the most important proteins involved in myogenesis and metabolism. The results indicated that BZ significantly downregulated NCoR 1 expression, and further induced muscle differentiation and metabolism by regulating NCoR1‑associated gene expression in vivo and in vitro. In summary, the present study indicated that may be effective in combating weightlessness‑induced muscle atrophy. Combined with bioinformatics, the underlying mechanism for this decoction was investigated, which provided an improved understanding of this decoction.

Indexed as

AnimalsCell LineDrug Delivery SystemsDrugs, Chinese HerbalGene OntologyMaleMiceMuscle DevelopmentMuscular AtrophyNuclear Receptor Co-Repressor 1Oxidation-ReductionSignal TransductionWeightlessness Simulationbu-zhong-yi-qi-tangDrugs, Chinese HerbalNcor1 protein, mouseNuclear Receptor Co-Repressor 1

Identifiers

PMID28849026
PMCPMC5647051
OpenAlexW2745890790

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.